Analyst Price Target is $6.75
▲ +396.32% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Zymergen in the last 3 months. The average price target is $6.75, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 396.32% upside from the last price of $1.36.
Current Consensus is
The current consensus among 8 investment analysts is to hold stock in Zymergen.
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.